ISSN 0300-9092 (Print)
ISSN 2412-5679 (Online)

Immunogenetic mechanisms of recurrent pathological vaginal discharge in women of reproductive age

Uruymagova A.T., Mezhevitinova E.A., Donnikov A.E.

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, Moscow, Russia

Objective: To identify immunogenetic factors that predispose women of reproductive age to recurrent pathological vaginal discharge.
Materials and methods: This study enrolled 173 women of reproductive age: 59 with episodic pathological vaginal discharge, 74 with recurrent pathological discharge, and 40 healthy women (control group). Genotyping of single nucleotide polymorphisms (SNPs) in immune-regulatory genes (CD14, CTLA4, IFN-γ, IGF-2, IL-10, IL-12β, IL-18, IL-1α, IL-1β, IL-1R, IL-2, IL-4, IL-4R, IL-6, IL-6R, IL-8, TGFβ1, TNF, and MBL2) and genes associated with the neuroendocrine stress response (CRH, CRHR1, and CRHR22) was performed using PCR-based SNP typing. The expression of cytokine (IL-1β, IL-10, IL-18, and TNF-α) and innate immunity receptor (TLR4) mRNAs in vaginal samples was measured by real-time RT-PCR. Statistical analysis included comparisons of allele/genotype frequencies, risk ratio (RR) calculations with 95% confidence intervals, χ² test, Mann–Whitney test, and multivariate logistic regression (significance at p<0.05).
Results: Recurrent pathological vaginal discharge was associated with alterations in local immune response. In the group with recurrent inflammatory discharge, there was significantly increased expression of the anti-inflammatory cytokine IL-10 and decreased IL-18 expression compared to episodic cases, indicating an imbalance in immune regulation. Patients with non-inflammatory recurrences exhibit a different immune profile, characterized by elevated levels of the pro-inflammatory cytokines TNF-α and IL-10. Statistically significant associations were identified between genetic variants and disease recurrence. The GG genotype of the IL-10 -1082 G>A polymorphism increased the risk of recurrent pathological discharge of both inflammatory and non-inflammatory origins, whereas the GG genotypes of the TNF-α -238 G>A polymorphism and CRHR1 (rs17689966) polymorphism significantly increased the likelihood of recurrence in cases of non-inflammatory discharge.
Conclusion: Recurrence of pathological vaginal discharge is driven by a combination of local immune imbalance and genetic predisposition. Polymorphisms in immune-related genes (IL-10, TNF, and CRHR1) may serve as molecular genetic markers of recurrence risk, paving the way for personalized prevention and treatment strategies.

Authors' contributions: Uruymagova A.T., Mezhevitinova E.A., Donnikov A.E. – conception and design of the study, obtaining data for analysis, review of relevant literature, analysis of the obtained data, drafting of the manuscript.
Conflicts of interest: The authors have no conflicts of interest to declare.
Funding: There was no funding for this study.
Ethical Approval: The study was reviewed and approved by the Research Ethics Committee of the V.I. Kulakov NMRC for OG&P, Ministry of Health of Russia.
Patient Consent for Publication: All patients provided informed consent for the publication of their data.
Authors' Data Sharing Statement: The data supporting the findings of this study are available upon request from the corresponding author after approval from the principal investigator.
For citation: Uruymagova A.T., Mezhevitinova E.A., Donnikov A.E. Immunogenetic mechanisms of 
recurrent pathological vaginal discharge in women of reproductive age.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2025; (7): 103-111 (in Russian)
https://dx.doi.org/10.18565/aig.2025.138

Keywords

immunogenetics
recurrent vaginal discharge
bacterial vaginosis
aerobic vaginitis
gene polymorphisms
cytokines

References

  1. Coudray M.S., Madhivanan P. Bacterial vaginosis – a brief synopsis of the literature. Eur. J. Obstet. Gynecol. Reprod. Biol. 2019; 245: 143-8. https://dx.doi.org/10.1016/j.ejogrb.2019.12.035
  2. Donders G.G.G., Bellen G., Grinceviciene S., Ruban K., Vieira-Baptista P. Aerobic vaginitis: no longer a stranger. Res. Microbiol. 2017; 168(9-10): 845-58. https://dx.doi.org/10.1016/j.resmic.2017.04.004
  3. Sherrard J., Wilson J., Donders G., Mendling W., Jensen J.S. European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int. J. STD AIDS. 2018; 29(13): 1258-72. https://dx.doi.org/10.1177/0956462418785451
  4. Geng N., Wu W., Fan A., Han C., Wang C., Wang Y. et al. Analysis of the risk factors for aerobic vaginitis: a case-control study. Gynecol. Obstet. Invest. 2015. https://dx.doi.org/10.1159/000431286
  5. Muzny C.A., Sunesara I.R., Austin E.L., Mena L.A., Schwebke J.R. Bacterial vaginosis among African American women who have sex with women. Sex. Transm. Dis. 2013; 40(9): 751-5. https://dx.doi.org/10.1097/OLQ.0000000000000004
  6. Hunt S., Vollenhoven B. Pelvic inflammatory disease and infertility. Aust. J. Gen. Pract. 2023; 52(4): 229-33. https://dx.doi.org/10.31128/AJGP-09-22-6576
  7. Gillet E., Meys J.F.A., Verstraelen H., Verhelst R., Sutter P. de, Temmerman M. et al. Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and meta-analysis. PLOS One. 2012; 7(10): e45201. https://dx.doi.org/10.1371/journal.pone.0045201
  8. Ji L., Peng C., Bao X. Effect of vaginal flora on clinical outcome of frozen embryo transfer. Front. Cell. Infect. Microbiol. 2022; 12: 987292. https://dx.doi.org/10.3389/fcimb.2022.987292
  9. Nguyen A.T.C., Nguyen N.T.L., Hoang T.T.A., Nguyen T.T., Tran T.T.Q., Tran D.N.T. et al. Aerobic vaginitis in the third trimester and its impact on pregnancy outcomes. BMC Pregnancy Childbirth. 2022; 22(1): 432. https://dx.doi.org/10.1186/s12884-022-04761-5
  10. Dingens A.S., Fairfortune T.S., Reed S., Mitchell C. Bacterial vaginosis and adverse outcomes among full-term infants: a cohort study. BMC Pregnancy Childbirth. 2016; 16(1): 278. https://dx.doi.org/10.1186/s12884-016-1073-y
  11. Workowski K.A., Bolan G.A.; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm. Rep. 2015; 64(RR-03): 1-137.
  12. Donders G.G., Vereecken A., Bosmans E., Dekeersmaecker A., Salembier G., Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG. 2002; 109(1): 34-43. https://dx.doi.org/10.1111/j.1471-0528.2002.00432.x
  13. Taylor B.D., Darville T., Ferrell R.E., Ness R.B., Kelsey S.F., Haggerty C.L. Cross-sectional analysis of Toll-like receptor variants and bacterial vaginosis in African-American women with pelvic inflammatory disease. Sex. Transm. Infect. 2014; 90(6): 436-41. https://dx.doi.org/10.1136/sextrans-2014-051524
  14. Mackelprang R.D., Scoville C.W., Cohen C.R., Ondondo R.O., Bigham A.W., Celum C., et al. Toll-like receptor gene variants and bacterial vaginosis among HIV-1 infected and uninfected African women. Genes Immun. 2015; 16(5): 362. https://dx.doi.org/10.1038/gene.2015.13
  15. Murphy K., Shi Q., Hoover D.R., Adimora A.A., Alcaide M.L., Brockmann S. et al. Genetic predictors for bacterial vaginosis in women living with and at risk for HIV in the United States. Am. J. Reprod. Immunol. 2024; 91(1): e13845. https://dx.doi.org/10.1111/aji.13845
  16. Kalia N., Singh J., Rauniyar A.K., Kaur M. A meta-analysis of mannose-binding lectin gene polymorphisms with the risk of recurrent vulvovaginal infections. Sci. Rep. 2020; 10(1): 6079. https://dx.doi.org/10.1038/s41598-020-63261-8
  17. De Seta F., Maso G., Piccoli M., Bianchini E., Crovella S., De Santo D. et al. The role of mannose-binding lectin gene polymorphisms in women with recurrent bacterial vaginosis. Am. J. Obstet. Gynecol. 2007; 197(6): 613.e1-e3. https://dx.doi.org/10.1016/j.ajog.2007.04.009
  18. Kalia N., Singh J., Kaur M. Immunopathology of recurrent vulvovaginal infections: new aspects and research directions. Front. Immunol. 2019; 10: 2034. https://dx.doi.org/10.3389/fimmu.2019.02034
  19. Usyk M., Schlecht N.F., Pickering S., Williams L., Sollecito C.C., Gradissimo A. et al. molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history. Nat. Commun. 2022; 13(1): 233. https://dx.doi.org/10.1038/s41467-021-27628-3
  20. Ge G., Yang Z., Li D. Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis. Front. Immunol. 2022; 13: 959740. https://dx.doi.org/10.3389/fimmu.2022.959740
  21. Atashili J., Poole C., Ndumbe P.M., Adimora A.A., Smith J.S. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008; 22(12): 1493-501. https://dx.doi.org/10.1097/QAD.0b013e3283021a37
  22. Larsson L., Rymo L., Berglundh T. Sp1 binds to the G allele of the -1087 polymorphism in the IL-10 promoter and promotes IL-10 mRNA transcription and protein production. Genes Immun. 2010; 11(2): 181-7. https://dx.doi.org/10.1038/gene.2009.103
  23. Cauci S., Santolo M. di, Casabellata G., Ryckman K., Williams S.M., Guaschino S. Association of interleukin-1beta and interleukin-1 receptor antagonist polymorphisms with bacterial vaginosis in non-pregnant Italian women. Mol. Hum. Reprod. 2007; 13(4): 243-50. https://dx.doi.org/10.1093/molehr/gam002
  24. Ryckman K.K., Simhan H.N., Krohn M.A., Williams S.M. Predicting risk of bacterial vaginosis: the role of race, smoking and corticotropin-releasing hormone-related genes. Mol Hum Reprod. 2009; 15(2): 131-7. https://dx.doi.org/10.1093/molehr/gan081
  25. White S., Acierno R., Ruggiero K.J., Koenen K.C., Kilpatrick D.G., Galea S. et al. Association of CRHR1 variants and posttraumatic stress symptoms in hurricane exposed adults. J. Anxiety Disord. 2013; 27(7): 678-83. https://dx.doi.org/10.1016/j.janxdis.2013.08.003

Received 27.05.2025

Accepted 18.06.2025

About the Authors

Ada T. Uruymagova, PhD student at the Department of Obstetrics, Gynecology, Perinatology and Reproductology, V.I. Kulakov NMRC for OGP, Ministry of Health of Russia, 4 Ac. Oparina str., Moscow, 117997, Russia, +7(925)704-33-97, ada.uruimagova@yandex.ru, https://orcid.org/0000-0001-5650-3377
Elena A. Mezhevitinova, Dr. Med. Sci., Leading Researcher at the Scientific and Outpatient Department, V.I. Kulakov NMRC for OGP, Ministry of Health of Russia,
4 Ac. Oparina str., Moscow, 117997, Russia, mejevitinova@mail.ru, https://orcid.org/0000-0003-2977-9065
Andrey E. Donnikov, PhD, Head of the Laboratory of Molecular Genetic Methods, V.I. Kulakov NMRC for OGP, Ministry of Health of Russia,
4 Ac. Oparina str., Moscow, 117997, Russia, https://orcid.org/0000-0003-3504-2406

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.